Filing Details
- Accession Number:
- 0001104659-14-052998
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-23 16:48:08
- Reporting Period:
- 2014-07-21
- Filing Date:
- 2014-07-23
- Accepted Time:
- 2014-07-23 16:48:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1474896 | Julie Brooks | Veracyte, Inc. 7000 Shoreline Court, Suite 250 South San Francisco CA 94080 | Exec Vp,General Coun,Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-07-21 | 1,000 | $14.00 | 1,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-07-22 | 1,000 | $14.36 | 2,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- This purchase of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 21, 2014.
- Represents weighted average purchase price. Actual purchase prices ranged from $13.98 to $14.02.
- Represents weighted average purchase price. Actual purchase prices ranged from $14.15 to $14.46.
Billionaire Hedge Funds
